Vasta Platform Limited (NASDAQ:VSTA – Get Free Report) was the target of a significant decrease in short interest during the month of July. As of July 15th, there was short interest totalling 9,200 shares, a decrease of 21.4% from the June 30th total of 11,700 shares. Currently, 0.1% of the shares of the stock are short sold. Based on an average daily volume of 32,000 shares, the days-to-cover ratio is presently 0.3 days.
Wall Street Analysts Forecast Growth
Separately, Morgan Stanley downgraded Vasta Platform from an “equal weight” rating to an “underweight” rating and reduced their price objective for the stock from $4.50 to $3.00 in a report on Friday, June 21st.
Read Our Latest Research Report on Vasta Platform
Vasta Platform Trading Down 1.6 %
Vasta Platform (NASDAQ:VSTA – Get Free Report) last announced its quarterly earnings data on Wednesday, May 8th. The company reported $0.13 earnings per share for the quarter, beating the consensus estimate of $0.12 by $0.01. Vasta Platform had a negative net margin of 3.90% and a positive return on equity of 1.84%. The business had revenue of $93.06 million for the quarter, compared to analyst estimates of $91.17 million. As a group, research analysts expect that Vasta Platform will post 0.3 EPS for the current fiscal year.
Vasta Platform Company Profile
Vasta Platform Limited provides educational printed and digital solutions to private schools operating in the K-12 education sector in Brazil. The company offers digital and printed textbooks, teacher handbooks, exercise books, multidisciplinary subject books, and student evaluations; and PAR platform that allows schools to select their preferred books and materials and follow their own specific teaching methods.
Featured Stories
- Five stocks we like better than Vasta Platform
- The Most Important Warren Buffett Stock for Investors: His Own
- Kimberly-Clark Stock Dips and a Buying Opportunity Emerges
- How to Invest in Small Cap StocksĀ
- Leading Gold Stock Shines With Q2 2024 Earnings Release
- 3 Stocks to Consider Buying in October
- Pharma Giant’s Shares Up After Impressive Q2 Earnings Release
Receive News & Ratings for Vasta Platform Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vasta Platform and related companies with MarketBeat.com's FREE daily email newsletter.